238
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion–spheronization

ORCID Icon, , &
Pages 632-642 | Received 10 Aug 2017, Accepted 31 Oct 2017, Published online: 07 Dec 2017

References

  • Serajuddin AT. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci. 1999;88:1058–1066.
  • Helliwell M, Taylor D. Solid oral dosage forms. Prof Nurse. 1993;8:313–317.
  • Alderborn G. Tablets and Compaction. In: Aulton ME, Taylor KMG, editors. Aulton’s pharmaceutics: the design and manufacture of medicines. 4th ed. New York: Elsevier; 2013. p. 505.
  • Aschenbrenner DS. Drug Administration. In: Aschenbrenner DS, Venable SJ, editors. Drug administration in nursing. 4th ed. Philadelphia: Lippincott, Williams, and Wilkins; 2009. p. 29.
  • Allen LV, Jr. Dosage form design and development. Clin Ther. 2008;30:2102–2111.
  • Muley S, Nandgude T, Poddar S. Extrusion–spheronization a promising pelletization technique: in-depth review. Asian J Pharm Sci. 2016 2016;11:684–699.
  • Davis SS, Hardy JG, Fara JW. Transit of pharmaceutical dosage forms through the small intestine. Gut. 1986;27:886–892.
  • Dressman JB. Comparison of canine and human gastrointestinal physiology. Pharm Res. 1986;3:123–131.
  • Dukic-Ott A, Thommes M, Remon JP, et al. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review. Eur J Pharm Biopharm. 2009;71:38–46.
  • Thommes M, Kleinebudde P. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler. Eur J Pharm Biopharm. 2006;63:59–67.
  • Tang ESK, Chan LW, Heng PWS. Coating of multiparticulates for sustained release. Am J Drug Deliv. 2005;3:17–28.
  • Mughal MA, Saripella KK, Kouba C, et al. Coated hydralazine hydrochloride beads for sustained release after oral administration. Drug Dev Ind Pharm. 2013;39:1439–1446.
  • Garekani HA, Nokhodchi A, Rayeni MA, et al. Preparation and characterization and release properties of Eudragit RS based ibuprofen pellets prepared by extrusion spheronization: effect of binder type and concentration. Drug Dev Ind Pharm. 2013;39:1238–1246.
  • Saripella KK, Loka NC, Mallipeddi R, et al. A quality by experimental design approach to assess the effect of formulation and process variables on the extrusion and spheronization of drug-loaded pellets containing polyplasdone(R) XL-10. AAPS PharmSciTech. 2016;17:368–379.
  • Garekani HA, Dolatabadi R, Akhgari A, et al. Evaluation of ethylcellulose and its pseudolatex (Surelease) in preparation of matrix pellets of theophylline using extrusion-spheronization. Iran J Basic Med Sci. 2017;20:9–16.
  • Alvarez L, Concheiro A, Gomez-Amoza J, et al. Effect of microcrystalline cellulose grade and process variables on pellets prepared by extrusion-spheronization. Drug Dev Ind Pharm. 2002;28:451–456.
  • Liew CV, Gu L, Soh JL, et al. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose. Pharm Res. 2005;22:1387–1398.
  • Bühler V. Insoluble polyvinylpyrrolidone (Crospovidone). In: Bühler V, editor. Polyvinylpyrrolidone excipients for pharmaceuticals: povidone, crospovidone and povidone. Berlin/Heidelberg: Springer; 2005. p. 125–178.
  • Hartauer KJ, Arbuthnot GN, Baertschi SW, et al. Influence of peroxide impurities in povidone and crospovidone on the stability of raloxifene hydrochloride in tablets: identification and control of an oxidative degradation product. Pharm Dev Technol. 2000;5:303–310.
  • USFDA. Advisory to Drug and Dietary Supplement Manufacturers, Compounding Pharmacies and Distributors of Excipients and Dietary Ingredients – FDA Detects High Levels of Peroxide in Crospovidone. In: Services USDoHaH, editor. Silver Spring (MD): USFDA; 2010.
  • Verheyen P, Steffens KJ, Kleinebudde P. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties. Drug Dev Ind Pharm. 2009;35:1325–1332.
  • Douroumis DD, Gryczke A, Schminke S. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets. AAPS PharmSciTech. 2011;12:141–151.
  • Sinha VR, Agrawal MK, Kumria R. Influence of formulation and excipient variables on the pellet properties prepared by extrusion spheronization. Curr Drug Deliv. 2005;2:1–8.
  • Koo OM, Heng PW. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization. Chem Pharm Bull (Tokyo). 2001;49:1383–1387.
  • Sarkar S, Wong TW, Liew CV. Importance of wet packability of component particles in pellet formation. AAPS PharmSciTech. 2013;14:1267–1277.
  • Saripella KK, Mallipeddi R, Neau SH. Crospovidone interactions with water. I. Calorimetric study of the effect of Polyplasdone particle size on its uptake and distribution of water. J Pharm Sci. 2014;103:669–675.
  • Saripella KK, Mallipeddi R, Neau SH. Crospovidone interactions with water. II. Dynamic vapor sorption analysis of the effect of Polyplasdone particle size on its uptake and distribution of water. Int J Pharm. 2014;475:174–180.
  • Agrawal AM, Howard MA, Neau SH. Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables. Pharm Dev Technol. 2004;9:197–217.
  • Saripella KKV. Crospovidone in water uptake and extrusion-spheronization studies: particle size effects [Dissertation]. Philadelphia: University of the Sciences in Philadelphia; 2012.
  • Shamblin SL. Controlled release using bilayer osmotic tablet technology: reducing theory to practice. In: Wen H, Park K, editors. Oral controlled release formulation design and drug delivery. Hoboken (NJ): John Wiley & Sons, Inc.; 2010. p. 129–153.
  • Wu N, Wang LS, Tan DC, et al. Mathematical modeling and in vitro study of controlled drug release via a highly swellable and dissoluble polymer matrix: polyethylene oxide with high molecular weights. J Control Release. 2005;102:569–581.
  • Pinto JF, Wunder KF, Okoloekwe A. Evaluation of the potential use of poly(ethylene oxide) as tablet- and extrudate-forming material. AAPS J. 2004;6:17–26.
  • Howard MA, Neau SH, Sack MJ. PEO and MPEG in high drug load extruded and spheronized beads that are devoid of MCC. Int J Pharm. 2006;307:66–76.
  • Mallipeddi R, Saripella KK, Neau SH. Use of coarse ethylcellulose and PEO in beads produced by extrusion-spheronization. Int J Pharm. 2010;385:53–65.
  • Mallipeddi R, Saripella KK, Neau SH. Use of fine particle ethylcellulose as the diluent in the production of pellets by extrusion-spheronization. Saudi Pharm J. 2014;22:360–372.
  • Muraoka M, Hu Z, Shimokawa T, et al. Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. J Control Release. 1998;52:119–129.
  • Eissenberg T, Griffiths RR. Human drug discrimination and multiple chemical sensitivity: caffeine exposure as an experimental model. Environ Health Perspect. 1997;105:509–513.
  • Friedman M, Donbrow M, Samuelov Y. Release rate of drugs from ethyl cellulose coated granules containing caffeine and salicylic acid. Drug Dev Ind Pharm. 1979;5:407–424.
  • Rostami-Hodjegan A, Tucker GT. Simulation and prediction of in vivo drug metabolism in human populations from in vitro data. Nat Rev Drug Discov. 2007;6:140–148.
  • Collins TJ. ImageJ for microscopy. Biotechniques 2007;43:25–30.
  • Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis [10.1038/nmeth.2089]. Nat Methods. 2012;9:671–675.
  • Hartig SM. Basic image analysis and manipulation in ImageJ. In: Hartig SM, editors. Current protocols in molecular biology. Hoboken (NJ): John Wiley & Sons, Inc.; 2001.
  • Dukić-Ott A, De Beer T, Remon JP, et al. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation. Eur J Pharm Biopharm. 2008;70:302–312.
  • Li JX, Zhou Y, Wu XY, et al. Characterization of wet masses of pharmaceutical powders by triaxial compression test. J Pharm Sci. 2000;89:178–190.
  • Sarfraz A, Simo A, Fenger R, et al. Morphological diversity of caffeine on surfaces: needles and hexagons. Cryst Growth Des. 2012;12:583–588.
  • Nayak AK, Maji R, Biswarup D. Gastroretentive drug delivery systems: a review [Review]. Asian J Pharm Clin Res. 2010;3:2–10.
  • Washington N, Washington C, Wilson C. Oesophageal transit. In: Washington N, Washington C, Wilson C, editors. Physiological pharmaceutics: barriers to drug absorption. 2nd ed. Boca Raton (FL): CRC Press; 2000. p. 59–71.
  • Veena MC, Senthil KS, Parthiban S. Pelletization technique in drug delivery system – a review. Int J Pharm Dev Technol. 2013;3:13–22.
  • Myers RH, Montgomery DC, Anderson-Cook CM. Response surface methodology: process and product optimization using designed experiments. (Wiley series in probability and statistics). 3rd ed. Hoboken (NJ): Wiley; 2009.
  • Shah KR, Chaudhary SA, Mehta TA. Polyox (Polyethylene Oxide) multifunctional polymer in novel drug delivery system [Review]. Int J Pharm Sci Drug Res. 2014;6:95–101.
  • Asghar A, Samad YA, Hashaikeh R. Cellulose/PEO blends with enhanced water absorption and retention functionality. J Appl Polym Sci. 2012;125:2121–2127.
  • Kleinebudde P, Schroder M, Schultz P, et al. Importance of the fraction of microcrystalline cellulose and spheronization speed on the properties of extruded pellets made from binary mixtures. Pharm Dev Technol. 1999;4:397–404.
  • Hasznos L, Langer I, Gyarmathy M. Some factors influencing pellet characteristics made by an Extrusion/Spheronisation process. Part I: effects on size characteristics and moisture content decrease of pellets. Drug Dev Ind Pharm. 1992;18:409–437.
  • Vertommen J, Kinget R. The influence of five selected processing and formulation variables on the particle size, particle size distribution, and friability of pellets produced in a rotary processor. Drug Dev Ind Pharm. 1997;23:39–46.
  • Scherer GW. Theory of drying. J Am Ceram Soc. 1990;73:3–14.
  • Millili GP, Wigent RJ, Schwartz JB. Autohesion in Pharmaceutical Solids. Drug Dev Ind Pharm. 1990;16:2383–2407.
  • Montgomery DC. Introduction to factorial designs. In: Montgomery DC, editor. Design and analysis of experiments. 7th ed. Hoboken (NJ): Wiley; 2008.
  • Conine J, Hadley H. Preparation of small solid pharmaceutical spheres. Drug Cosmet Ind. 1970;106:38–41.
  • Koester M, Thommes M. New insights into the pelletization mechanism by extrusion/spheronization. AAPS PharmSciTech. 2010;11:1549–1551.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.